Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

LOUISVILLE, Ky.--( BUSINESS WIRE )--Fast-growing CenterWell Senior Primary Care will continue expanding in 2023, announcing plans to open in new markets including Indiana, Mississippi and Virginia, as well as opening new centers in seven other states where CenterWell already is active.

CenterWell Senior Primary Care 2023 Expansion Plan Includes New Markets of Indiana, Mississippi and Virginia

Health insurance stocks have been a safe haven as the market grapples with inflation and a strong dollar. As inflation recedes, defensive sector selling should create attractive entry points for Humana and its peers.

Humana: Top-Rated Medicare Advantage Insurer With Room To Grow

Caterpillar

McKesson

Marathon Petroleum

O'Reilly Automotive

We have narrowed our search to five U.S. corporate behemoths with solid growth potential. These are: HUM, MPC, CAT, MCK and ORLY.

October CPI Data Raises Hope for a Soft Landing: 5 Top Picks

Humana stock stands out as it leads the managed health care industry and gets ready to form a new three-weeks-tight base. The post Humana Stock Leads Managed Care Industry; Nears Buy Point As It Forms New Base appeared first on Investor's Business Daily.

Humana Stock Leads Managed Care Industry; Nears Buy Point As It Forms New Base

Humana recently received recognition as U.S. News & World Report's Best Insurance Company for Medicare Advantage in three categories for 2023 -- best company for Medicare Advantage plan overall rating, best company for member experience, and best company for low-premium plan availability. U.S. News analyzed data from the Center for Medicare and Medicaid Services (CMS) to populate its comparison tool and identify the best companies nationwide and in each state. (Graphic: Business Wire)

U.S. News and World Report names Humana 2023 Best Overall Medicare Advantage Plan Company

CenterWell Senior Primary Care Brings Personalized Primary Care to Louisville, Opening 3 Centers by mid-2023

AM Best Assigns Issue Credit Rating to Humana Inc.'s Senior Unsecured Notes

Associated Banc-Corp

Halliburton

Kroger

Pure Storage

As brokers have a deeper insight into stocks, one must follow rating upgrades before investing. We pick Kroger (KR), Halliburton (HAL), Humana (HUM), Associated Banc-Corp (ASB) and Pure Storage (PSTG), as these have seen rating upgrades recently.

5 Stocks With Upgraded Broker Ratings to Fight Recession Risk

Shares of Humana Inc. HUM, +0.92% rose 0.8% in premarket trading Thursday, after the health insurer disclosed that it entered into a $1 billion accelerated stock repurchase (ASR) agreement. The company said the agreement, made with Goldman Sachs & Co. GS, +0.35% and Mizuho Markets America.

Humana stock gains after $1 billion ASR set

Humana Inc. (NYSE:HUM ) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Lisa Stoner – Vice President-Investor Relations Bruce Broussard – President and Chief Executive Officer Susan Diamond – Chief Financial Officer Conference Call Participants Stephen Baxter – Wells Fargo Kevin Fischbeck – Bank of America Justin Lake – Wolfe Research Nathan Rich – Goldman Sachs Gary Taylor – Cowen Scott Fidel – Stephens George Hill – Deutsche Bank Josh Raskin – Nephron Research A.J. Rice – Credit Suisse Michael Ha – Morgan Stanley Lisa Gill – JPMorgan Steven Valiquette – Barclays Rob Cottrell – Cleveland Research Operator Ladies and gentlemen, thank you for standing by, and welcome to the Q3 2022 Humana Inc. Earnings Call.

Humana Inc. (HUM) Q3 2022 Earnings Call Transcript

Humana (HUM) delivered earnings and revenue surprises of 10.08% and 0.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Humana (HUM) Tops Q3 Earnings Estimates

The health-insurance company said its top line was boosted by an increase in individual Medicare Advantage and state-based membership growth and higher per-member individual Medicare Advantage premiums.

Humana's Revenue Up 10% on Rise in Medicare Membership, Premiums

Shares of Humana Inc. HUM, -0.64% were indicated up fractionally in premarket trading Wednesday, after the health insurer reported third-quarter profit that beat expectations while sales came up a touch shy, and affirmed its full-year outlook. Net income fell to $1.30 billion, or $9.39 a share, from $1.64 billion, or $11.84 a share, in the year-ago period.

Humana beats profit expectations and affirms 2022 outlook, but revenue comes up a touch shy

Humana Reports Third Quarter 2022 Financial Results; Affirms Recent Upward Revision to Full Year 2022 Adjusted EPS Financial Guidance

Humana has an impressive earnings track record, exceeding the Zacks Consensus EPS Estimate in each quarter dating all the way back to 2016.

Humana Q3 Preview: Can The Earnings Streak Continue?

Humana's (HUM) Q3 results are expected to reflect growing premiums, attributable to its Medicare Advantage and Medicaid businesses. However, elevated marketing costs might have strained its margins.

Can Humana (HUM) Sustain Its Earnings Beat Streak in Q3?

“Healthcare” has done well this year in an otherwise down market and it still has opportunities that are worth buying, says Gina Sanchez – Chief Market Strategist at Lido Advisors.

Sanchez: this healthcare stock at an all-time high is still worth owning

Humana, Monogram Health Announce New Agreement that Enhances In-home Kidney Care in Four States

Elevance Health Inc

All three stocks are up double-digit percentages in 2022, leaving the S&P 500's performance in the dust. With the stocks carrying favorable near-term earnings outlooks, the run could easily continue.

3 Top-Ranked Medical Stocks Lapping the S&P 500

MEDNAX

Teladoc

Recovering volumes, improved admissions, growing health awareness and wide utilization of technologies in the third quarter are expected to have aided healthcare stocks like Humana (HUM), Teladoc (TDOC) and Pediatrix Medical (MD).

3 Healthcare Stocks Set to Outshine Q3 Earnings Estimates

Humana expands Medicare Advantage health plan offerings into Rhode Island, Wyoming and 140 new counties nationwide in 2023

Technology will bundle and accelerate prior authorization for cardiovascular and surgical services BOSTON , Oct. 24, 2022 /PRNewswire/ -- Today Cohere Health, a leader in intelligent utilization management (UM) technology, announced that Humana Inc.  (NYSE: HUM) will expand its use of Cohere's digital UM collaboration platform to enable seamless prior authorization for cardiovascular and surgical services. In addition to digitizing prior authorization requests for these services, the technology automates clinical intelligence into the provider's workflow, enabling episode-based, longitudinal management of the patient's care journey to reduce care variation, drive higher quality care, and minimize administrative burden.

Cohere Health and Humana Expand Partnership to Further Improve Physician and Member Experiences

CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits

Humana Announces Major Expansion of Florida Dental Network, Benefits

Humana (HUM) ties up with USAA Life to develop a Medicare Advantage plan that transcends the VA system to fetch added healthcare benefits for veterans.

News for Humana Stock (HUM)